News & Updates

Mild cognitive impairment common in hypertensive patients
Mild cognitive impairment common in hypertensive patients
12 Oct 2021

Mild cognitive impairment (MCI) is common among patients with hypertension, reports a recent meta-analysis. Early screening is needed in this population to facilitate timely intervention.

Mild cognitive impairment common in hypertensive patients
12 Oct 2021
Continuous vital sign monitoring catches COVID-19 deterioration early
Continuous vital sign monitoring catches COVID-19 deterioration early
11 Oct 2021
CV risk remains elevated in metabolically healthy obese
CV risk remains elevated in metabolically healthy obese
08 Oct 2021 byRoshini Claire Anthony

Individuals who are obese but without metabolic abnormalities (metabolically healthy obese [MHO]) have an elevated risk of developing MACE-HF*, new-onset heart failure (HF), and new-onset atrial fibrillation (AF), according to a French study presented at EASD 2021.

CV risk remains elevated in metabolically healthy obese
08 Oct 2021
Noncardiac surgery after stenting ups myocardial infarction risk in ACS, SAP patients
Noncardiac surgery after stenting ups myocardial infarction risk in ACS, SAP patients
07 Oct 2021

In patients with acute coronary syndrome (ACS) or stable angina pectoris (SAP), undergoing noncardiac surgery after stenting increases the risk of myocardial infarction (MI), but only when procedures are performed during acute admission, a recent study has found.

Noncardiac surgery after stenting ups myocardial infarction risk in ACS, SAP patients
07 Oct 2021
CV safety of degarelix vs leuprolide: Results remain inconclusive
CV safety of degarelix vs leuprolide: Results remain inconclusive
06 Oct 2021 byRoshini Claire Anthony

In men with prostate cancer and concomitant atherosclerotic cardiovascular disease (ASCVD), major adverse cardiovascular event (MACE) incidence did not differ between those who were treated with degarelix or leuprolide, according to findings of the PRONOUNCE trial.

CV safety of degarelix vs leuprolide: Results remain inconclusive
06 Oct 2021